Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease
Open Access
- 9 January 2024
- journal article
- review article
- Published by Springer Nature in Translational Neurodegeneration
- Vol. 13 (1) , 1-26
Abstract
Alzheimer’s disease (AD) is the most prevalent form of dementia in the elderly and represents a major clinical challenge in the ageing society. Neuropathological hallmarks of AD include neurofibrillary tangles composed of hyperphosphorylated tau, senile plaques derived from the deposition of amyloid-β (Aβ) peptides, brain atrophy induced by neuronal loss, and synaptic dysfunctions. Death-associated protein kinase 1 (DAPK1) is ubiquitously expressed in the central nervous system. Dysregulation of DAPK1 has been shown to contribute to various neurological diseases including AD, ischemic stroke and Parkinson’s disease (PD). We have established an upstream effect of DAPK1 on Aβ and tau pathologies and neuronal apoptosis through kinase-mediated protein phosphorylation, supporting a causal role of DAPK1 in the pathophysiology of AD. In this review, we summarize current knowledge about how DAPK1 is involved in various AD pathological changes including tau hyperphosphorylation, Aβ deposition, neuronal cell death and synaptic degeneration. The underlying molecular mechanisms of DAPK1 dysregulation in AD are discussed. We also review the recent progress regarding the development of novel DAPK1 modulators and their potential applications in AD intervention. These findings substantiate DAPK1 as a novel therapeutic target for the development of multifunctional disease-modifying treatments for AD and other neurological disorders.Keywords
Funding Information
- National Natural Science Foundation of China (82001128, 81970993, 82271449)
- Natural Science Foundation of Fujian Province (2021J01672)
This publication has 236 references indexed in Scilit:
- Death Associated Protein Kinases: Molecular Structure and Brain InjuryInternational Journal of Molecular Sciences, 2013
- The cholinergic system in aging and neuronal degenerationBehavioural Brain Research, 2011
- Death-Associated Protein Kinase 1 Phosphorylates Pin1 and Inhibits Its Prolyl Isomerase Activity and Cellular FunctionMolecular Cell, 2011
- Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase InhibitorsJournal of the American Chemical Society, 2011
- DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicityCell Death & Differentiation, 2011
- Phosphorylation-dependent control of ZIPK nuclear import is species specificCellular Signalling, 2011
- The Dependence Receptor UNC5H2/B Triggers Apoptosis via PP2A-Mediated Dephosphorylation of DAP KinaseMolecular Cell, 2010
- DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in StrokeCell, 2010
- No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's diseaseNeurobiology of Aging, 2009
- Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid betaneurogenetics, 2008